Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xenia Wezler

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Human Antibodies|April 26, 2018
Antibody fusion proteins with human ribonucleases 1 to 8Xenia Wezler, Stefan Dübel, Thomas Schirrmann
Human Antibodies|August 14, 2012
Human antibodies targeting CD30(+) lymphomasXenia Wezler, Michael Hust, Saskia Helmsing, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 18, 2013
CD30 as a therapeutic target for lymphomaThomas Schirrmann, Miriam Steinwand, Xenia Wezler, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Back-to-Germline (B2G) Procedure for Antibody DevolutionAnja Schrade, Alexander Bujotzek, Christian Spick, et al.
Plos One|August 14, 2009
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatusMark Schütte, Philippe Thullier, Thibaut Pelat, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Human Antibodies|April 26, 2018
Antibody fusion proteins with human ribonucleases 1 to 8Xenia Wezler, Stefan Dübel, Thomas Schirrmann
Human Antibodies|August 14, 2012
Human antibodies targeting CD30(+) lymphomasXenia Wezler, Michael Hust, Saskia Helmsing, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 18, 2013
CD30 as a therapeutic target for lymphomaThomas Schirrmann, Miriam Steinwand, Xenia Wezler, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Back-to-Germline (B2G) Procedure for Antibody DevolutionAnja Schrade, Alexander Bujotzek, Christian Spick, et al.
Plos One|August 14, 2009
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatusMark Schütte, Philippe Thullier, Thibaut Pelat, et al.
Pageof 1